Learn everything you need to know about breast cancer: causes, symptoms, diagnosis, treatment, and patient support. Discover effective prevention methods.
Table of Contents
- What is breast cancer? Epidemiology and risk factors
- Most common causes of breast cancer
- Breast cancer symptoms – what to look for?
- Diagnostics and early detection of breast cancer
- Treatment methods and prognosis in breast cancer
- Psychological and social support for breast cancer patients
What is breast cancer? Epidemiology and risk factors
Breast cancer is a malignant tumor that arises from the cells of the mammary gland, caused by the uncontrolled division and proliferation of abnormal cells. It is the most common malignant tumor in women worldwide and one of the leading causes of cancer-related deaths in this group. However, it should be emphasized that breast cancer also affects men – although such cases are much rarer, accounting for less than 1% of all incidences. The epidemiology of breast cancer shows a constantly increasing number of new diagnoses. According to World Health Organization data, over 2.2 million new cases of breast cancer are recorded globally each year, and in Poland nearly 20,000 women receive this diagnosis annually. High incidence rates are particularly observed in highly developed countries, but they are also rising in developing nations due to lifestyle changes and aging populations. The frequency of the disease increases with age – the majority of cases are diagnosed in women over 50 years old, though it is increasingly detected in younger women as well. Statistics show that the lifetime risk is as high as 1 in 8 women, with some populations particularly vulnerable due to genetic and environmental factors.
Many risk factors influence the development of breast cancer, which can be divided into non-modifiable factors (genetic and innate traits) and modifiable ones (lifestyle and environmental factors). The main non-modifiable factors include age – the risk increases significantly after age 50, as well as family history, meaning the presence of breast or ovarian cancer in close relatives, especially when the disease occurred at a young age. Of particular importance is the presence of mutations in the BRCA1 and BRCA2 genes, which drastically increase the risk of developing breast and other cancers. Other genetic factors include mutations in CHEK2, PTEN, TP53, and PALB2 genes. Hormonal factors also play a significant role – early onset of menstruation (before age 12), late menopause (after age 55), nulliparity or having the first child after age 30, as well as long-term use of hormone replacement therapy increase the risk of breast cancer. Modifiable risk factors include overweight and obesity (especially after menopause), insufficient physical activity, an unhealthy diet rich in saturated fats and processed foods, excessive alcohol consumption, and smoking. Increased risk is also associated with exposure to ionizing radiation, such as during treatment of another cancer in youth. Recent research indicates that risk factors may be cumulative – women with genetic predispositions are even more affected by unhealthy lifestyles. Having awareness of both non-modifiable and modifiable risk factors is essential for prevention and early detection of breast cancer. Identifying your personal risk profile allows for the implementation of appropriate protective measures, more frequent screening tests, and the adoption of a healthy lifestyle, all of which can genuinely lower the likelihood of developing the disease.
Most common causes of breast cancer
Breast cancer has a complex etiology, with multiple overlapping contributing factors. The most important are genetic, hormonal, environmental, and personalized lifestyle-related factors. A key cause is genetic predisposition – women with mutations in the BRCA1 and BRCA2 genes, as well as PALB2, TP53, or CHEK2, are at significantly greater risk compared to the general population. Hereditary predisposition most often manifests in familial cases – if a close relative (mother, sister, daughter) develop breast or ovarian cancer, the risk is several times higher. Another significant factor is hormonal – particularly exposure to estrogens and progesterone. Elevated levels of these over long periods accelerate the division of breast cells, increasing the likelihood of cancerous mutations. High-risk groups include women who start menstruating early (before age 12), have late menopause (after age 55), use hormone replacement therapy for a long time, do not have children, have their first child after age 35, or do not breastfeed.
Lifestyle factors also play a major role in cancer development. Excess weight and obesity, especially after menopause, lead to increased estrogen production by fat tissue, thereby further increasing hormonal effects on breast tissue. The effects of physical inactivity, a high-calorie low-fiber diet, alcohol abuse, and smoking on cancer risk are well documented. Alcohol disturbs estrogen metabolism, causing its accumulation, while cigarette smoke toxins damage cellular genetic material, fostering mutations. Environmental factors include exposure to ionizing radiation, particularly at a young age (for example, as a result of chest radiotherapy in childhood or adolescence) and chronic exposure to certain chemicals. It’s also worth mentioning the impact of overall health: type 2 diabetes, chronic stress, metabolic disturbances, or chronic inflammation can increase susceptibility to breast cancer through effects on the immune system and DNA repair mechanisms. The simultaneous occurrence of these causes, especially their accumulation, greatly influences not only individual risk but the course of the disease, highlighting the need for personalized risk assessment and modification of harmful factors where possible.
Breast cancer symptoms – what to look for?
Early detection of breast cancer is crucial for effective treatment and prognosis, which is why it is very important for every woman to know the most common symptoms to look for during breast self-exams and regular medical checkups. The most typical sign of breast cancer is the appearance of a lump in the breast – usually it is painless, hard, and has irregular edges, although sometimes it can be well-defined and resemble a benign lesion. Not every lump is cancerous, but each such change requires immediate consultation with a doctor, especially if it persists through more than one menstrual cycle. Changes in the shape or size of the breast, dimpling or retraction of the skin, differences in the height or contours of the nipples, or drooping of one breast compared to the other can also be signs of cancer. Important symptoms also include any changes to the skin of the breast – warmth, redness, excessive keratosis (orange-peel appearance), or swelling, which may indicate local infiltration or a cancerous process in the subcutaneous lymphatic vessels. Ulcerations, bleeding lesions, non-healing wounds, or palpable thickening all need immediate differential diagnosis. Additionally, some patients may experience breast pain or tenderness, although these complaints are more typical in benign conditions, such as fibrocystic breast disease, and rarely point to cancer in its early stage. Another significant, though less obvious, symptom is the enlargement of lymph nodes under the arm or near the collarbone – enlarged, hard, and movable nodes might indicate metastasis or the first signs of cancer development in regional lymphatic structures even without clear breast changes.
Breast cancer symptoms can also be less obvious and are sometimes ignored or mistaken for harmless conditions. These include any abnormal nipple discharge, especially if it contains blood, is serous, or is milky in women not currently in lactation or occurs only on one side. Pay attention to retraction of the nipple, changes in its shape, or ulceration or scaling and redness of the skin around it. Advanced stages of cancer may result in generalized symptoms like weight loss, chronic fatigue, unexplained fever, as well as bone pain, shortness of breath, or cough – these suggest possible metastases. It’s also worth mentioning that breast cancer in men is usually recognized more quickly because their glandular tissue is smaller – most often presenting as a hard lump under the nipple, redness or skin indentation, or enlarged regional lymph nodes. It’s essential to conduct regular breast self-exams and report any worries to your doctor, even if they seem trivial or only occur occasionally. Also remember that some types of breast cancer, such as inflammatory cancer, are extremely fast-growing and aggressive, and their clinical presentation can resemble breast infections (sudden swelling, redness, raised temperature, severe pain), often causing delays in proper diagnosis. That is why being aware of all, even minor and atypical changes in the breast or lymph nodes, is crucial for early detection and successful treatment of breast cancer.
Diagnostics and early detection of breast cancer
Early diagnosis of breast cancer is the cornerstone of an effective fight against the disease, increasing the chances of cure and reducing the invasiveness of potential treatments. The key to prevention is regular screening, the most important of which is mammography, recommended every two years for women aged 50–69 and even more frequently—and from a younger age—for those at higher risk, following individual guidelines. Mammography can detect lesions just a few millimeters in diameter, long before they can be palpated. For younger women with denser glandular tissue, breast ultrasound (USG) is also advised, as it helps differentiate benign cysts from suspicious lesions. Monthly breast self-examination during days 7–10 of the menstrual cycle is also widely advised. Through regular observation, women can detect worrying symptoms, such as lumps, thickening, changes in the skin, or abnormal nipple discharge. Education about self-examinations and raising awareness of the symptoms are integral to effective breast cancer prevention, as a significant portion of cases are detected by the women themselves.
When worrying changes are found through imaging or self-examination, the next diagnostic step is to confirm or rule out cancer, often using core needle or fine needle biopsy, where a sample of the suspicious tissue is taken for histopathological examination. The test result identifies the tumor type, its malignancy, and biological features such as the presence of hormone receptors (estrogen and progesterone) and HER2 receptor – all crucial for selecting the right treatment. In clinical practice, diagnostic tools also include breast magnetic resonance imaging (MRI), particularly in difficult cases, for surgical planning, or to detect tumors in individuals with BRCA mutations. Additional examinations like chest X-ray, abdominal ultrasound, and bone scintigraphy help assess for possible metastases and disease stage. Breast cancer diagnosis also involves medical history and clinical examination, assessing breasts, armpits, and supraclavicular regions for enlarged lymph nodes. Modern technology—tomosynthesis, elastography, or genetic panel testing—increases the sensitivity of detecting pathological changes and allows identification of individuals at risk of hereditary breast cancer. Implementing national screening programs and active cooperation between the patient, general practitioner, and oncologist are critical to ensure prompt recognition of abnormalities and initiation of appropriate therapy, ideally when the disease is still asymptomatic or preclinical.
Treatment methods and prognosis in breast cancer
Treatment of breast cancer is a complex process, tailored individually to the tumor characteristics and the patient’s general health. The choice of therapeutic strategy is determined by factors such as histological tumor type, clinical stage (TNM classification), hormone receptor status (ER, PR), HER2 receptor expression, the patient’s age, personal preferences, and any coexisting conditions. The most radical approach is surgery, which can be breast-conserving (removal of only part of the gland with a margin of healthy tissue – so-called lumpectomy) or mastectomy (complete removal of the breast). The choice depends on the size, location, and spread of the lesion, as well as anatomical factors. Surgery is often accompanied by removal of axillary lymph nodes to assess spread or by sentinel node biopsy, which can substantially reduce the risk of complications such as lymphedema. After surgery, adjuvant therapies are typically administered: radiotherapy and systemic treatment. Radiotherapy is mainly used after breast-conserving surgery to destroy any remaining cancer cells and minimize recurrence risk. In some instances, it can be combined with chemotherapy, especially for tumors with unfavorable biological features.
Systemic treatment includes chemotherapy, hormone therapy, and targeted therapies. Chemotherapy involves administering cytostatics intravenously or orally, destroying cancer cells locally and in any potential metastases. It’s most often used in advanced or aggressive breast cancer cases, as well as before (neoadjuvant chemotherapy) or after surgery (adjuvant chemotherapy) to improve treatment outcomes. Hormone therapy is given to patients whose tumors have hormone receptors (estrogen or progesterone). Drugs such as tamoxifen, aromatase inhibitors, or gonadotropin-releasing hormone analogues disrupt hormone action and inhibit tumor growth. Targeted therapies, particularly monoclonal antibodies like trastuzumab or pertuzumab, are directed against HER2 overexpression, markedly improving prognosis in these patients. In triple-negative breast cancer, therapeutic options are limited, but immunotherapy and novel targeted treatments have become more important in recent years. Prognosis for breast cancer depends closely on the stage at detection – outcomes are best for women diagnosed at early stages, with five-year survival rates exceeding 90%. Prognosis is also influenced by the biological subtype, grade, lymph node involvement, and effectiveness of treatment. Distant metastases (most often to bone, lung, liver, brain) significantly worsen survival prospects – in these cases, therapy focuses on improving quality of life and symptom relief. Nonetheless, advances in modern therapies and improved diagnostics have regularly improved outlooks for breast cancer patients, with comprehensive care now also encompassing psychological support, rehabilitation, and health education to help women through the treatment process and back to wellness as comfortably as possible.
Psychological and social support for breast cancer patients
A breast cancer diagnosis is associated not only with physical treatment, but above all with enormous emotional, psychological, and social burden. Many patients experience fear of death, concern for the future of loved ones, anxiety about their own attractiveness and the ability to return to normal life. They grapple with feelings of threat, helplessness, loss of control, and often face an identity crisis. As treatment progresses, additional challenges arise: side effects of therapy, chronic fatigue, and body changes such as hair loss, breast deformity, or postoperative complications. For many women, simply undergoing invasive treatment is a traumatic experience that can lead to depression, anxiety, and even adjustment disorders or post-traumatic stress disorder (PTSD). Deterioration of family relationships, social withdrawal, and isolation are among the most common psychological consequences. That’s why the presence of a qualified psycho-oncologist, psychologist, or psychotherapist in the care team is so important – especially at every stage of treatment, from diagnosis, through therapy, to the return to daily life after completing oncology treatment.
Social support, both from loved ones and professional support groups, plays a key role in the process of recovery and adaptation to life with cancer. Family, partners, friends, and colleagues have a significant impact on patients’ sense of safety, motivation, and psychological balance. Openness to dialogue and acceptance of the emotions that arise during treatment are invaluable. Many patients benefit from support groups, both traditional (run by foundations and associations) and online communities dedicated to people with breast cancer, where they can share experiences, ask questions, and receive practical advice. The presence of people with similar experiences provides a sense of understanding and belonging, alleviating feelings of isolation. Another important aspect is help in dealing with daily challenges, e.g., with childcare, arranging transportation to treatment, or financial support so patients can focus on recovery. The Polish healthcare system is increasingly offering access to comprehensive psycho-oncological and social services, such as workshops, legal consultations, or vocational guidance, which help patients navigate the changes caused by illness. The joint efforts of health organizations, local communities, and state institutions help increase the availability and quality of support, making it easier for patients to go through treatment and adapt to life after recovery. Integrating systematic psychological and social support into care standards for breast cancer patients not only improves quality of life, but also positively affects treatment outcomes, motivation to follow recommendations, and restoration of independence.
Summary
Breast cancer is one of the most common cancers in women, so awareness of the symptoms, risk factors, and the importance of regular screening is crucial. Modern treatment methods are steadily improving patient prognosis. Equally important is appropriate psychological and social support throughout the entire course of treatment and recovery. By focusing on early prevention and making use of available help, we boost our chances of full recovery and a comfortable life. Don’t be afraid to ask for support – together, you can beat breast cancer.
